[1]
|
Petruzziello, A., Marigliano, S., Loquercio, G., Cozzolino, A. and Cacciapuoti, C. (2016) Global Epidemiology of Hepa-titis C Virus Infection: An Up-Date of the Distribution and Circulation of Hepatitis C Virus Genotypes. World Journal of Gastroenterology, 22, 7824-7840. https://doi.org/10.3748/wjg.v22.i34.7824
|
[2]
|
Smith, D.B., Bukh, J., Kuiken, C., Muerhoff, A.S., Rice, C.M., Stapleton, J.T. and Simmonds, P. (2014) Expanded Classification of Hepatitis C Virus into 7 Genotypes and 67 Subtypes: Updated Criteria and Genotype Assignment Web Resource. Hepatology, 59, 318-327. https://doi.org/10.1002/hep.26744
|
[3]
|
Morozov, V.A. and Lagaye, S. (2018) Hepatitis C Virus: Morphogenesis, Infection and Therapy. World Journal of Hepatology, 10, 186-212. https://doi.org/10.4254/wjh.v10.i2.186
|
[4]
|
张莉娟, 刘炳华, 马翠华. 《2018年世界卫生组织慢性HCV感染的管理和治疗指南》摘译[J]. 临床肝胆病杂志, 2018, 34(10): 2121-2123.
|
[5]
|
Coppola, N., Alessio, L., Onorato, L., Sagnelli, C., Macera, M., Sagnelli, E. and Pisa-turo, M. (2019) Epidemiology and Management of Hepatitis C Virus Infections in Immigrant Populations. Infectious Diseases of Poverty, 8, Article No. 17. https://doi.org/10.1186/s40249-019-0528-6
|
[6]
|
American Association for the Study of Liver Diseases and the Infectious Diseases Society of America (n.d.) HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. https://www.hcvguidelines.org/
|
[7]
|
Saeed, Y.A., Phoon, A., Bie-lecki, J.M., Mitsakakis, N., Bremner, K.E., Abrahamyan, L., Pechlivanoglou, P., Feld, J.J., Krahn, M. and Wong, W.W.L. (2020) A Systematic Review and Meta-Analysis of Health Utilities in Patients with Chronic Hepatitis C. Value in Health, 23, 127-137. https://doi.org/10.1016/j.jval.2019.07.005
|
[8]
|
Roudot-Thoraval, F. (2021) Epidemiology of Hepatitis C Virus Infection. Clinics and Research in Hepatology and Gastroenterology, 45, Article ID: 101596. https://doi.org/10.1016/j.clinre.2020.101596
|
[9]
|
Carrat, F., Fontaine, H., Dorival, C., Simony, M., Diallo, A., Hezode, C., De Ledinghen, V., Larrey, D., Haour, G., Bronowicki, J.P., Zoulim, F., Asselah, T., Marcellin, P., Thabut, D., Leroy, V., Tran, A., Habersetzer, F., Samuel, D., Guyader, D., Chazouilleres, O., et al. (2019) Clinical Outcomes in Patients with Chronic Hepatitis C after Direct-Acting Antiviral Treatment: A Prospective Cohort Study. Lancet, 393, 1453-1464.
https://doi.org/10.1016/S0140-6736(18)32111-1
|
[10]
|
Belli, L.S., Perricone, G., Adam, R., Cortesi, P.A., Strazza-bosco, M., Facchetti, R., Karam, V., Salizzoni, M., Andujar, R.L., Fondevila, C., De Simone, P., Morelli, C., Fa-bregat-Prous, J., Samuel, D., Agarwaal, K., Moreno Gonzales, E., Charco, R., Zieniewicz, K., De Carlis, L., Duvoux, C., et al. (2018) Impact of DAAs on Liver Transplantation: Major Effects on the Evolution of Indications and Results. An ELITA Study Based on the ELTR Registry. Journal of Hepatology, 69, 810-817. https://doi.org/10.1016/j.jhep.2018.06.010
|
[11]
|
Messina, J.P., Humphreys, I., Flaxman, A., Brown, A., Cooke, G.S., Pybus, O.G. and Barnes, E. (2015) Global Distribution and Prevalence of Hepatitis C Virus Genotypes. Hepatolo-gy, 61, 77-87. https://doi.org/10.1002/hep.27259
|
[12]
|
Polaris Observatory HCV Collaborators (2017) Global Prevalence and Genotype Distribution of Hepatitis C Virus Infection in 2015: A Modelling Study. The Lancet Gastroen-terology and Hepatology, 2, 161-176.
https://doi.org/10.1016/S2468-1253(16)30181-9
|
[13]
|
Zhang, Y., Chen, L.-M. and He, M. (2017) Hepatitis C Virus in Mainland China with an Emphasis on Genotype and Subtype Distribution. Virology Journal, 14, Article No. 41. https://doi.org/10.1186/s12985-017-0710-z
|
[14]
|
Rao, H., Wei, L., Lopez-Talavera, J.C., Shang, J., Chen, H., Li, J., Xie, Q., Gao, Z., Wang, L., Wei, J., Jiang, J., Sun, Y., Yang, R., Li, H., Zhang, H., Gong, Z., Zhang, L., Zhao, L., Dou, X., Niu, J., et al. (2014) Distribution and Clinical Correlates of Viral and Host Genotypes in Chinese Patients with Chronic Hepatitis C Virus Infection. Journal of Gastroenterology and Hepatology, 29, 545-553. https://doi.org/10.1111/jgh.12398
|
[15]
|
中华医学会肝病学分会, 中华医学会感染病学分会. 丙型肝炎防治指南(2022年版) [J]. 中华肝脏病杂志, 2022, 30(12): 1332-1348.
|
[16]
|
Halfon, P., Trimoulet, P., Bourliere, M., Khiri, H., de Lédinghen, V., Couzigou, P., Feryn, J.M., Alcaraz, P., Renou, C., Fleury, H.J. and Ouzan, D. (2001) Hepatitis C Vi-rus Genotyping Based on 5’ Noncoding Sequence Analysis (Trugene). Journal of Clinical Microbiology, 39, 1771-1773. https://doi.org/10.1128/JCM.39.5.1771-1773.2001
|
[17]
|
Antonishyn, N.A., Ast, V.M., McDonald, R.R., Chaudhary, R.K., Lin, L., Andonov, A.P. and Horsman, G.B. (2005) Rapid Genotyping of Hepatitis C Virus by Pri-mer-Specific Extension Analysis. Journal of Clinical Microbiology, 43, 5158-5163. https://doi.org/10.1128/JCM.43.10.5158-5163.2005
|
[18]
|
Verbeeck, J., Stanley, M.J., Shieh, J., Celis, L., Huyck, E., Wollants, E., Morimoto, J., Farrior, A., Sablon, E., Jankowski-Hennig, M., Schaper, C., Johnson, P., Van Ranst, M. and Van Brussel, M. (2008) Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0. Journal of Clinical Microbiology, 46, 1901-1906.
https://doi.org/10.1128/JCM.02390-07
|
[19]
|
Yukimasa, N., Yoshida, K., Ohkushi, H., Tanabe, S., Fukasawa, K., Kanou, M., Fukuchi, K., Takagi, Y. and Gomi, K. (2001) Rinshobyori. The Japanese Journal of Clinical Pathology, 49, 711-715.
|
[20]
|
周一萌, 窦晓光, 张琳. 丙型肝炎病毒基因分型检测方法研究进展[J]. 中国实用内科杂志, 2014, 34(8): 819-822.
|
[21]
|
Lindh, M. and Hannoun, C. (2005) Genotyping of Hepatitis C Virus by Taqman Real-Time PCR. Journal of Clinical Virology, 34, 108-114. https://doi.org/10.1016/j.jcv.2005.02.002
|
[22]
|
Lee, M.-H., Yang, H.-I., Lu, S.-N., Jen, C.-L., You, S.-L., Wang, L.-Y., L'Italien, G., Chen, C.-J. and Yuan, Y. (2014) Hepatitis C Virus Geno-type 1b Increases Cumulative Lifetime Risk of hepaTocellular Carcinoma. International Journal of Cancer, 135, 1119-1126. https://doi.org/10.1002/ijc.28753
|
[23]
|
Ampuero, J., Romero-Gómez, M. and Reddy, K.R. (2014) Re-view Article: HCV Genotype 3—The New Treatment Challenge. Alimentary Pharmacology & Therapeutics, 39, 686-698. https://doi.org/10.1111/apt.12646
|
[24]
|
Aytug, S., Reich, D., Sapiro, L.E., Bernstein, D. and Begum, N. (2003) Impaired IRS-1/PI3-Kinase Signaling in Patients with HCV: A Mechanism for Increased Prevalence of Type 2 Diabetes. Hepatology, 38, 1384-1392.
https://doi.org/10.1016/j.hep.2003.09.012
|
[25]
|
Shi, S.T., Polyak, S.J., Tu, H., Taylor, D.R., Gretch, D.R. and Lai, M.M. (2002) Hepatitis C Virus NS5A Colocalizes with the Core Protein on Lipid Droplets and Interacts with Apolipo-proteins. Virology, 292, 198-210.
https://doi.org/10.1006/viro.2001.1225
|
[26]
|
Yang, J., Liu, H.-X., Su, Y.-Y., Liang, Z.-S. and Rao, H.-Y. (2022) Distribution and Changes in Hepatitis C Virus Genotype in China from 2010 to 2020. World Journal of Clinical Cases, 10, 4480-4493.
https://doi.org/10.12998/wjcc.v10.i14.4480
|
[27]
|
杨慧洁, 虞莉莎, 殷雪瑞, 等. CHC患者HCV基因分型及与肝功能指标的关系[J]. 医学研究杂志, 2020, 9(5): 93-96, 75.
|
[28]
|
Peta, V., Torti, C., Milic, N., Focà, A. and Abe-navoli, L. (2015) Adiponectin Serum Level in Chronic Hepatitis C Infection and Therapeutic Profile. World Journal of Hepatology, 7, 44-52. https://doi.org/10.4254/wjh.v7.i1.44
|
[29]
|
Hézode, C., Roudot-Thoraval, F., Zafrani, E.-S., Dhumeaux, D. and Pawlotsky, J.-M. (2004) Different Mechanisms of Steatosis in Hepatitis C Virus Genotypes 1 and 3 Infections. Journal of Viral Hepatitis, 11, 455-458.
https://doi.org/10.1111/j.1365-2893.2004.00528.x
|
[30]
|
Rubbia-Brandt, L., Quadri, R., Abid, K., Giostra, E., Malé, P.J., Mentha, G., Spahr, L., Zarski, J.P., Borisch, B., Hadengue, A. and Negro, F. (2000) Hepatocyte Steatosis Is a Cy-topathic Effect of Hepatitis C Virus Genotype 3. Journal of Hepatology, 33, 106-115. https://doi.org/10.1016/S0168-8278(00)80166-X
|
[31]
|
Papageorgiou, L., Vlachakis, C., Dragoumani, K., Raftopoulou, S., Brouzas, D., Nicolaides, N.C., Chrousos, G.P., Charmandari, E., Megalooikonomou, V. and Vlachakis, D. (2017) HCV Genetics and Genotypes Dictate Future Antiviral Strategies. Journal of Molecular Biochemistry, 6, 33-40.
|
[32]
|
赵鹏, 王磊. 聚乙二醇化干扰素-α对不同基因型慢性丙型肝炎患者治疗效果比较[J]. 实用肝脏病杂志, 2019, 22(1): 57-60.
|
[33]
|
Moradpour, D., Brass, V., Gosert, R., Wölk, B. and Blum, H.E. (2002) Hepatitis C: Mo-lecular Virology and Antiviral Targets. Trends in Molecular Medicine, 8, 476-482. https://doi.org/10.1016/S1471-4914(02)02395-X
|
[34]
|
Di Biagio, A., Taramasso, L. and Cenderello, G. (2018) Treatment of Hepatitis C Virus Genotype 4 in the DAA Era. Virology Journal, 15, Article No. 180. https://doi.org/10.1186/s12985-018-1094-4
|